Greggs PLC Directorate Change

RNS Number : 2346J

Greggs PLC

04 April 2024

 

 

4 April 2024

 

GREGGS plc

 

Appointment of Non-Executive Director

The Board of Greggs plc is pleased to announce that it has appointed Tamara Rogers as an independent non-executive director with effect from 1^st June 2024. The Board intends that on appointment Tamara will join the Audit, Remuneration and Nominations Committees.

Tamara is currently the Chief Marketing Officer of Haleon plc, the FTSE100 listed world-leading consumer healthcare company, and has over 30 years' experience across a range of commercial and marketing roles. Tamara joined GSK in 2018 having spent almost 25 years with Unilever plc, where she held significant leadership positions, and was appointed as CMO at Haleon ahead of its demerger from GSK and listing in 2022.  

Matt Davies, Chair of Greggs, said "We are delighted to announce Tamara's appointment to our Board. She brings a wealth of experience across marketing, customer insight, and digital commerce which will be of significant value as Greggs continues its journey as a multi-channel consumer business."

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Tamara Rogers.

ENDS

ENQUIRIES:
Greggs plc	Hudson Sandler
Roisin Currie, Chief Executive Richard Hutton, Chief Financial Officer	Wendy Baker / Hattie Dreyfus / Nick Moore
Tel:  [phone]	Tel:  [phone]

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAUPUMACUPCGMW